[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-HRTX":3,"homepage-market-summary":31,"stock-news-HRTX":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"HRTX","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Heron Therapeutics, Inc.","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.","128","San Diego, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},0.3476,0.36,0.405,0.34,0.3559,-0.0083,-2.33,4064702.27457,10806,0.372,1.58,0.261,2367814.560453516,6.6,9849,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},11,[176,182,188,193,199,205,210,216,221,226,231],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Heron Therapeutics Stock Price Forecast. Should You Buy HRTX? - StockInvest.us","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiSEFVX3lxTE9DRktyNklKb1NnRzNzUmk5RktkckNyQjA2c09zYWxkSVdHdlJCZURHVW03Uy1pSUMtTHpJbG12cnhxZHpjelAwdg?oc=5","Fri, 02 Oct 2026 22:28:18 GMT","Heron Therapeutics Stock Price Forecast. Should You Buy HRTX? StockInvest.us","StockInvest.us",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Has Consensus Target Price of $2.00 - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1AFBVV95cUxPU1pqSXdqb216SFhCZmZZVzVCeHlzY19Vc1NTamZ3M0swWU8wS3RaZVZXYUFtZEtmTk5YRWpnXzdmSmxiUExJME9QaXF4VHVhS3NLQjJvVkIwTDRzS2QzTTB4X28teFJsYnZoQ3FKUXlJQ3JCX1R1Rnl3OEtpdFRmMG9YNjZ0WU1DLUo5Uy1veW9yb2VpQlBKbFpIUEJZek9ZMkdwOHRKSFVLZW0zcW9aOHlmUm5CYmtyYkkwNjBxWWJPNGV4UmRNV1FGZHlQLUNrWF9uag?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Has Consensus Target Price of $2.00 MarketBeat","MarketBeat",{"title":189,"link":190,"pubDate":185,"description":191,"source":192},"PTC Therapeutics grants stock options and RSUs to 37 new employees as hiring incentives. - Pluang","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirgFBVV95cUxObmNoSDNudVlRNVhUS0JNRkZwX2hFVGtqQTdqQ2plbmNDNWdKY3M2eGJTYWdtWl9QZHpoeThld0NGbXc2cDlUeVRLTmhrU0JpeWVqc3hid1V4VVBVX0VKYlV1Wm5WeXRZYktHZnhJWllkZDQzMjVucEVjYXB2SHNKZ21wX0xQQy0wSDI1ejQwR2RYOXpxZTd4YUJRUi16eFFOckdKWDJsZVQxaURSRmc?oc=5","PTC Therapeutics grants stock options and RSUs to 37 new employees as hiring incentives. Pluang","Pluang",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"Form 8K Heron Therapeutics Inc For: 29 September By Investing.com - Investing.com Nigeria","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirAFBVV95cUxPeUZQVUc1N3VtNjlRdVgxWEZMU2IwZXZ1LVVKRDdlTHZLTFl2TmpyNGVlOEJfUXZtZS0tSjFZZG1qajBmSjNKbE1ZYU5xbkMwbnY2SVJMcHA4QUg5a2s5cUJTcm9GZ0xyNl90Nzc5NWVfRnNVU3lQWWJDNi1aLVV4TVlwaEdMZ09sTlJCVjVFNGxGekVyQUdiUUdWODY3MmJrRGNuemJnQ1UwNmRE?oc=5","Wed, 30 Sep 2026 00:01:47 GMT","Form 8K Heron Therapeutics Inc For: 29 September By Investing.com Investing.com Nigeria","Investing.com Nigeria",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Heron Therapeutics stock fell 2.33 percent on October 2 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxPUGdrUTdrQnhKUzh3dHhSOV8xc0d3aUNJMS1BVF9EYWxNTFFKWTc4SkMzYkN4VjJQUmNGRFFyRXY0TW5BbGFqNjFyeE5VanlnOGkydTBiR0lSRkY0QXFfTWNvemw0d091SXdJZHVIb1RuVU1ZbS1OcFhxRjY3Um9ScWFUc2lRd1Y5RHY2VGJFZHBkWlR1Nm9Fd3ZsM3N1dXZTTmc0MkFaMmlOMzlzQjJGQnF5Uk56bWxoZGc?oc=5","Mon, 05 Oct 2026 09:58:00 GMT","Heron Therapeutics stock fell 2.33 percent on October 2 AD HOC NEWS","AD HOC NEWS",{"title":206,"link":207,"pubDate":208,"description":209,"source":192},"Viking Therapeutics prices $275M stock and conv... - Pluang","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilgFBVV95cUxPdWQ5eUdSemxWdmctdmtyUjRwLVl1R0k4c2J6cHNkMnF3eWFhUU9EZ1RjZ0Q1Unc3WHNuQ3htdldCSVl1WklhWFl0X0U3RHNTZ0tmR2dPY0JyZGY5b3ZRZkJkajJIQXhET0pZX0RKSGt3ZXR4bXNGRkN3ZDhxQ3RXa3cxT25CZGhIdkQzT3JwZnNESEJPcGc?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","Viking Therapeutics prices $275M stock and conv... Pluang",{"title":211,"link":212,"pubDate":213,"description":214,"source":215},"Heron Therapeutics signs multi-product license agreement with Long Grove By Investing.com - Investing.com Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizAFBVV95cUxOS0lfV1N2b014VmdHaUROaVpEYXRZY3NzTVg3TmJOd3pHOFJFMEtBMjJ3Tkw3aFcyZUlVVVl1dGdieVNCWmlzVURtTDlnY2pLYnRhQ1czRlVnY3lOY0pPaF9XanFIQXpac3JUQy1qODhSd2RzQTZWRlNhc251Ujc4X0ctQmhUd2NwSFRkclZlZGVFek5fbDRMMTZ4MnVzUU5WUWtwcUNrZzNpdFVpb0JSRW5LekhEZmdKWTI2Y3MxNVN1Zmotd2JFc0RYOVY?oc=5","Tue, 29 Sep 2026 21:40:30 GMT","Heron Therapeutics signs multi-product license agreement with Long Grove By Investing.com Investing.com Canada","Investing.com Canada",{"title":217,"link":218,"pubDate":219,"description":220,"source":192},"NEOG stock drops 7.22% after FDA warns of funga... - Pluang","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxPSG9vZGd4ekc5ak9IanNNMlhSMlozZEE4dUkzdm9mcnE4eWl3MEg1N1B5SDJiQnFvWm5TQy10NmhXakhRU0t4RFlvaFNwcDltTjlfSW5rZ0hOZVE1bWZpSnZWeWZSN2dSZmhWRDhYZ2xLMXJsSzNXUG1GWHE3XzRsT2FneWR2OThRS0FGbEptTGRyY0xPV3JpNzZxUQ?oc=5","Wed, 30 Sep 2026 18:45:13 GMT","NEOG stock drops 7.22% after FDA warns of funga... Pluang",{"title":222,"link":223,"pubDate":224,"description":225,"source":192},"Replimune CEO and CFO sued for allegedly mislea... - Pluang","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqwFBVV95cUxPMlgwVXlobGF5OTRMQ1ZkRmFhd0tqZDYwc2NYZTE1al96V2xXQ0NMMUJyN3o2TWZ6bHhZS1Vqb3pPdFRtRnZwNk9udl9PNjZVdmo3bnFCVXJNb25tT0d4ZlYtOU9kOTdDRjh4Y0tjWDQtQ3FOU1U1OGtqUTdFMlJ3SjRieWFONlI5NEgxNWxHWmNUNjBURnI2NFFsRlczUWhMdG1FdW5XV282RUU?oc=5","Thu, 01 Oct 2026 14:25:36 GMT","Replimune CEO and CFO sued for allegedly mislea... Pluang",{"title":227,"link":228,"pubDate":229,"description":230,"source":192},"Cryoport shares jump 82% YTD on strong cell and gene therapy pipeline and profitability rebound - Pluang","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMifEFVX3lxTFBWUm9oLU9wZVdmM29FdmNjMW1nZm5MYjB3UDREWEFVVnpNMnVSQ0d2YXN2Uy1yY3NvY2VTcVpBWVdtS1BCNHVUMkdlb184a014V1hYYWVHR2ktdmY2SXdwSTdfUlpaV1ZLWW45ZXZOM3RLTHlyNFJhZklRRUo?oc=5","Fri, 25 Sep 2026 07:45:30 GMT","Cryoport shares jump 82% YTD on strong cell and gene therapy pipeline and profitability rebound Pluang",{"title":232,"link":233,"pubDate":234,"description":235,"source":192},"Class action lawsuit targets CooperCompanies ov... - Pluang","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilAFBVV95cUxPNE9ORU03MDNnVFZxS3NDTE10bVlreDZVLVA3RGx4X1Y2YmlWYU8wWDVOdF9nY3RXck85RW5vaUt5bTlBY0ZLMml4aUdsX3d4dG9XZ09tT2M4WU16dlppbXNrS0ZlZWlBSHRkZDRvd2RMb25sZzNNM0hnQWZ6Rzd5NzlFTGlOd3EyRWEzUlQwLTNMSllq?oc=5","Wed, 30 Sep 2026 00:27:11 GMT","Class action lawsuit targets CooperCompanies ov... Pluang"]